These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10705255)

  • 1. Pathogenesis of lung disease in cystic fibrosis.
    Dinwiddie R
    Respiration; 2000; 67(1):3-8. PubMed ID: 10705255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opportunities for the use of aerosolized alpha 1-antitrypsin for the treatment of cystic fibrosis.
    Allen ED
    Chest; 1996 Dec; 110(6 Suppl):256S-260S. PubMed ID: 8989161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.
    Birrer P; McElvaney NG; Rüdeberg A; Sommer CW; Liechti-Gallati S; Kraemer R; Hubbard R; Crystal RG
    Am J Respir Crit Care Med; 1994 Jul; 150(1):207-13. PubMed ID: 7912987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ceramide in cystic fibrosis.
    Grassmé H; Riethmüller J; Gulbins E
    Handb Exp Pharmacol; 2013; (216):265-74. PubMed ID: 23563661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CFTR-dependent susceptibility of the cystic fibrosis-host to Pseudomonas aeruginosa.
    Grassmé H; Becker KA; Zhang Y; Gulbins E
    Int J Med Microbiol; 2010 Dec; 300(8):578-83. PubMed ID: 20951085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MPB-07 reduces the inflammatory response to Pseudomonas aeruginosa in cystic fibrosis bronchial cells.
    Dechecchi MC; Nicolis E; Bezzerri V; Vella A; Colombatti M; Assael BM; Mettey Y; Borgatti M; Mancini I; Gambari R; Becq F; Cabrini G
    Am J Respir Cell Mol Biol; 2007 May; 36(5):615-24. PubMed ID: 17197571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipids in cystic fibrosis.
    Becker KA; Henry B; Ziobro R; Riethmüller J; Gulbins E
    Expert Rev Respir Med; 2011 Aug; 5(4):527-35. PubMed ID: 21859272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction to section I: overview of approaches to study cystic fibrosis pathophysiology.
    Clunes MT; Boucher RC
    Methods Mol Biol; 2011; 742():3-14. PubMed ID: 21547723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory mediators in cystic fibrosis lung disease.
    Berger M
    Allergy Asthma Proc; 2002; 23(1):19-25. PubMed ID: 11894730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation.
    Saadane A; Soltys J; Berger M
    J Allergy Clin Immunol; 2006 May; 117(5):1163-9. PubMed ID: 16675347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of IL-1β in experimental cystic fibrosis upon P. aeruginosa infection.
    Palomo J; Marchiol T; Piotet J; Fauconnier L; Robinet M; Reverchon F; Le Bert M; Togbe D; Buijs-Offerman R; Stolarczyk M; Quesniaux VF; Scholte BJ; Ryffel B
    PLoS One; 2014; 9(12):e114884. PubMed ID: 25500839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsin-G interferes with clearance of Pseudomonas aeruginosa from mouse lungs.
    Sedor J; Hogue L; Akers K; Boslaugh S; Schreiber J; Ferkol T
    Pediatr Res; 2007 Jan; 61(1):26-31. PubMed ID: 17211136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal models of chronic lung infection with Pseudomonas aeruginosa: useful tools for cystic fibrosis studies.
    Kukavica-Ibrulj I; Levesque RC
    Lab Anim; 2008 Oct; 42(4):389-412. PubMed ID: 18782827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of polynucleotides on the inhibition of neutrophil elastase by mucus proteinase inhibitor and alpha 1-proteinase inhibitor.
    Belorgey D; Bieth JG
    Biochemistry; 1998 Nov; 37(46):16416-22. PubMed ID: 9819234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CFTR, Pseudomonas aeruginosa and Toll-like receptors in cystic fibrosis lung inflammation.
    Buchanan PJ; Ernst RK; Elborn JS; Schock B
    Biochem Soc Trans; 2009 Aug; 37(Pt 4):863-7. PubMed ID: 19614608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An alpha 1-antitrypsin aerosol in the treatment of cystic fibrosis].
    Ferrer Calvete J; Aznar Lucea J; Morales Marín P; Pereda Pérez A; Llopis Carles R; Ribes Koninckx C; Ferrer González P; Marco Martínez V
    An Esp Pediatr; 1996 Feb; 44(2):109-11. PubMed ID: 8830566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to acute lung infection with mucoid Pseudomonas aeruginosa in cystic fibrosis mice.
    van Heeckeren AM; Schluchter MD; Xue W; Davis PB
    Am J Respir Crit Care Med; 2006 Feb; 173(3):288-96. PubMed ID: 16272448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between tumor necrosis factor-alpha and granulocyte elastase-alpha 1-proteinase inhibitor complexes in the plasma of patients with cystic fibrosis.
    Suter S; Schaad UB; Roux-Lombard P; Girardin E; Grau G; Dayer JM
    Am Rev Respir Dis; 1989 Dec; 140(6):1640-4. PubMed ID: 2604293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of anaerobic bacteria in the cystic fibrosis airway.
    Sherrard LJ; Bell SC; Tunney MM
    Curr Opin Pulm Med; 2016 Nov; 22(6):637-43. PubMed ID: 27455453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudomonas aeruginosa lipopolysaccharide induces CF-like alteration of protein secretion by human tracheal gland cells.
    Kammouni W; Figarella C; Baeza N; Marchand S; Merten MD
    Biochem Biophys Res Commun; 1997 Dec; 241(2):305-11. PubMed ID: 9425267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.